Potential nanocarrier-mediated miRNA-based therapy approaches for multiple sclerosis

Area of Science:

• Neuroscience
• Immunology
• Biotechnology

Background:

• Multiple sclerosis (MS) is an autoimmune neuroinflammatory disease characterized by neurodegeneration and demyelination.
• MicroRNAs (miRNAs) play a critical role in the biological processes underlying MS pathogenesis.
• Current therapeutic strategies for MS face challenges in effectively targeting the underlying molecular mechanisms.

Purpose of the Study:

• To review the potential of microRNA (miRNA) delivery using nanoformulations for managing multiple sclerosis (MS).
• To discuss miRNA synthesis, dysregulation in MS, and formulation strategies for nanocarrier-based delivery.
• To highlight the therapeutic benefits of advanced nanotechnologies in MS management.

Main Methods:

• Literature review focusing on miRNA biology in MS.
• Analysis of nanoformulation strategies for miRNA delivery.
• Evaluation of nanocarrier systems for therapeutic applications in MS.

Main Results:

• Evidence supports miRNA dysregulation in the pathogenesis of multiple sclerosis.
• Nanoformulations provide a feasible approach for targeted miRNA delivery in MS.
• Various nanocarrier systems show potential for enhancing therapeutic efficacy in MS.

Conclusions:

• MicroRNA-based therapies hold promise for treating multiple sclerosis.
• Nanotechnology offers innovative solutions for effective miRNA delivery in MS.
• Further research into nanoformulated miRNAs could lead to improved MS management strategies.